TechnoPhage, SA
  • About us
    • The company
    • Our track record
    • Quality Policy
  • Leadership
    • Board of Directors
    • Management Team
    • Scientific and Clinical Advisors
  • R&D
    • Product Pipeline
    • Therapeutic areas
  • GMP manufacturing
  • News Room
  • Contacts
Select Page

TechnoPhage selected by UK Trade & Investment for entry as a National Champion

31 Mai 2013 | News

TechnoPhage selected by UK Trade & Investment for entry as a National Champion in the European Business Awards 2013-2014 for Commercial Success, Innovation and Business Ethics. Read here the information.

TechnoPhage’s manuscript on animal efficacy for bacteriophage cocktail accepted for publication

31 Mai 2013 | News

TechnoPhage’s manuscript on animal efficacy for bacteriophage cocktail for the treatment of diabetic cutaneous wounds accepted for publication. Read here the publication.
Next Entries »

Recent news

  • TechnoPhage initiates Phase I/IIa study of TP-102 bacteriophage treatment for diabetic foot infections 24 de Fevereiro, 2021

Search by year

2011 (1) 2012 (9) 2013 (7) 2014 (5) 2015 (11) 2016 (4) 2017 (4) 2018 (2) 2019 (7) 2020 (4) 2021 (1)

TechnoPhage SA

Av. Prof. Egas Moniz
Edifício Egas Moniz, Piso 2 – Ala A
1649-028 Lisboa, Portugal

T. +(351) 21 799 9472
F. +(351) 21 799 9459

General inquires:  info@technophage.pt
Human resources:  hr@technophage.pt
Data protection:  dataprotection@technophage.pt

TechnoPhage, 2020 – All Rights Reserved | Designed by Digitalloft

  • Follow
  • Follow